Literature DB >> 397408

Complement activation in pneumonia.

U Nydegger, J J Farquet, R Zubler, P H Lambert, P A Miescher.   

Abstract

Complement analyses performed on serially collected plasma samples from 10 patients during acute infectious pneumonia or bronchopneumonia showed normal or increased values for hemolytic activity and Clq, C4, C3, and factor B levels. However, the levels of C3 breakdown products (C3d) were significantly (greater than 2 SD) increased in six patients during the first three days of observation, suggesting that hypercatabolism of complement components may occur during the acute phase of infectious pneumonia concomitant with a hypersynthesis of some complement components. Evidence of circulating immune complexes was obtained only in two patients with the 125I-Clq Binding Test.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 397408     DOI: 10.1007/bf02120811

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  21 in total

1.  Effect of mercaptoethanol on complement binding ability of human 7 S gammaglobulin.

Authors:  G WIEDERMANN; P A MIESCHER; E C FRANKLIN
Journal:  Proc Soc Exp Biol Med       Date:  1963-07

2.  Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.

Authors:  L H Perrin; P H Lambert; P A Miescher
Journal:  J Clin Invest       Date:  1975-07       Impact factor: 14.808

3.  The role of the capsular polysaccharide in the activation of the alternative pathway by the pneumococcus.

Authors:  J A Winkelstein; J A Bocchini; G Schiffman
Journal:  J Immunol       Date:  1976-02       Impact factor: 5.422

4.  C3 proactivator (C3PA) as an acute phase reactant.

Authors:  M Schutte; R DiCamelli; P Murphy; M Sadove; H Gewurz
Journal:  Clin Exp Immunol       Date:  1974-10       Impact factor: 4.330

5.  A simple automated method for complement estimation in a continuous flow system.

Authors:  U E Nydegger; L M Achermann; P H Lambert; P A Miescher
Journal:  J Immunol       Date:  1972-10       Impact factor: 5.422

6.  Activation of the properdin pathway of complement in patients with gram-negative of bacteremia.

Authors:  D T Fearon; S Ruddy; P H Schur; W R McCabe
Journal:  N Engl J Med       Date:  1975-05-01       Impact factor: 91.245

7.  Quantitation of C3PA (properdin factor B) and other complement components in diseases associated with a low C3 level.

Authors:  L H Perrin; P H Lambert; U E Nydegger; P A Miescher
Journal:  Clin Immunol Immunopathol       Date:  1973-11

8.  Detection of immune complexes in unheated sera by modified 125I-Clq binding test. Effect of heating on the binding of Clq by immune complexes and application of the test to systemic lupus erythematosus.

Authors:  R H Zubler; G Lange; P H Lambert; P A Miescher
Journal:  J Immunol       Date:  1976-01       Impact factor: 5.422

9.  Complement system in pneumococcal infections.

Authors:  W P Reed; M S Davidson; R C Williams
Journal:  Infect Immun       Date:  1976-04       Impact factor: 3.441

10.  Decreased heat-labile opsonic activity and complement levels associated with evidence of C3 breakdown products in infected pleural effusions.

Authors:  P D Lew; R Zubler; P Vaudaux; J J Farquet; F A Waldvogel; P H Lambert
Journal:  J Clin Invest       Date:  1979-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.